Company Filing History:
Years Active: 2022-2024
Title: The Innovative Contributions of Nicole Joy Bedke
Introduction
Nicole Joy Bedke is a prominent inventor based in Abingdon, GB. She has made significant strides in the field of immunotherapy, particularly through her work on T cell receptors. With a total of 3 patents to her name, Bedke is recognized for her innovative approaches to treating malignant diseases.
Latest Patents
Among her latest patents, Bedke has developed T cell receptors (TCRs) that specifically bind to the HLA-A*02 restricted peptide SLLQHLIGL, derived from the germline cancer antigen PRAME. These TCRs may include non-natural mutations within the alpha and/or beta variable domains compared to a native PRAME TCR. The TCRs she has invented are particularly suitable for use as novel immunotherapeutic reagents aimed at treating malignant diseases.
Career Highlights
Nicole Joy Bedke is currently associated with Immunocore Limited, where she continues to advance her research and development efforts. Her work has garnered attention for its potential impact on cancer treatment and immunotherapy.
Collaborations
Throughout her career, Bedke has collaborated with notable colleagues, including Philip William Addis and Lucie Bouard. These partnerships have contributed to her innovative research and the development of her patents.
Conclusion
Nicole Joy Bedke's contributions to the field of immunotherapy through her patents and collaborations highlight her role as a leading inventor. Her work continues to pave the way for advancements in the treatment of malignant diseases.